1. Home
  2. LOAN vs ASRT Comparison

LOAN vs ASRT Comparison

Compare LOAN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • ASRT
  • Stock Information
  • Founded
  • LOAN 1989
  • ASRT 1995
  • Country
  • LOAN United States
  • ASRT United States
  • Employees
  • LOAN N/A
  • ASRT N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAN Real Estate
  • ASRT Health Care
  • Exchange
  • LOAN Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • LOAN 57.7M
  • ASRT 65.7M
  • IPO Year
  • LOAN 1999
  • ASRT 1997
  • Fundamental
  • Price
  • LOAN $5.39
  • ASRT $0.61
  • Analyst Decision
  • LOAN
  • ASRT Strong Buy
  • Analyst Count
  • LOAN 0
  • ASRT 3
  • Target Price
  • LOAN N/A
  • ASRT $3.08
  • AVG Volume (30 Days)
  • LOAN 34.1K
  • ASRT 480.8K
  • Earning Date
  • LOAN 04-29-2025
  • ASRT 05-05-2025
  • Dividend Yield
  • LOAN 8.63%
  • ASRT N/A
  • EPS Growth
  • LOAN 2.37
  • ASRT N/A
  • EPS
  • LOAN 0.49
  • ASRT N/A
  • Revenue
  • LOAN $7,351,609.00
  • ASRT $124,961,000.00
  • Revenue This Year
  • LOAN N/A
  • ASRT N/A
  • Revenue Next Year
  • LOAN $2.18
  • ASRT $11.20
  • P/E Ratio
  • LOAN $10.90
  • ASRT N/A
  • Revenue Growth
  • LOAN 1.12
  • ASRT N/A
  • 52 Week Low
  • LOAN $4.74
  • ASRT $0.51
  • 52 Week High
  • LOAN $6.05
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 48.35
  • ASRT 39.17
  • Support Level
  • LOAN $4.83
  • ASRT $0.58
  • Resistance Level
  • LOAN $5.38
  • ASRT $0.80
  • Average True Range (ATR)
  • LOAN 0.25
  • ASRT 0.05
  • MACD
  • LOAN -0.02
  • ASRT 0.00
  • Stochastic Oscillator
  • LOAN 49.62
  • ASRT 34.48

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: